Long-term renal outcomes in patients with primary aldosteronism

被引:307
作者
Sechi, LA [1 ]
Novello, M [1 ]
Lapenna, R [1 ]
Baroselli, S [1 ]
Nadalini, E [1 ]
Colussi, GL [1 ]
Catena, C [1 ]
机构
[1] Univ Udine, Med Clin, Dept Expt & Clin Pathol & Med, Div Internal Med,Hypertens Unit, I-33100 Udine, Italy
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 22期
关键词
D O I
10.1001/jama.295.22.2638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Experimental animal studies indicate that exposure to increased aldosterone levels might result in renal damage, but the clinical evidence supporting this role of aldosterone is preliminary. Objective To determine the long-term outcome of renal function in patients with primary aldosteronism after surgical or medical treatment. Design, Setting, and Participants Prospective study conducted at an Italian university medical center among a consecutive sample of 50 patients who were diagnosed as having primary aldosteronism between January 1994 and December 2001 and who were followed up for a mean of 6.4 years after treatment with adrenalectomy or spironolactone. Patients with primary aldosteronism were compared with 100 patients with essential hypertension, matched for severity and duration of hypertension. All patients were treated with antihypertensive drugs to reach a target blood pressure of less than 140/90 mm Hg. Main Outcome Measures Primary outcome measures were rates of change of glomerular filtration rate and albuminuria during follow-up. Detection of new-onset microalbuminuria and restoration of normal albumin excretion during follow-up were considered as secondary outcomes. Results At baseline, glomerular filtration rate and albuminuria were higher in patients with primary aldosteronism than those with essential hypertension. The mean blood pressure during the study was 136/81 mm Hg in the primary aldosteronism group and 137/81 mm Hg in the essential hypertension group. Glomerular filtration rate and albuminuria declined during the initial 6-month period in both groups, with a change that was significantly greater ( P <. 001 for both variables) in patients with primary aldosteronism. Subsequent rate of decline of glomerular filtration was comparable in the 2 groups, whereas albuminuria did not progress in the remainder of the follow-up. Restoration of normal albumin excretion from microalbuminuria was significantly more frequent in primary aldosteronism than in essential hypertension ( P=. 02). Conclusion In the majority of patients in this study, primary aldosteronism was characterized by partially reversible renal dysfunction in which elevated albuminuria is a marker of a dynamic rather than structural renal defect.
引用
收藏
页码:2638 / 2645
页数:8
相关论文
共 39 条
[1]   Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole [J].
Arima, S ;
Kohagura, K ;
Xu, HL ;
Sugawara, A ;
Uruno, A ;
Satoh, F ;
Takeuchi, K ;
Ito, S .
HYPERTENSION, 2004, 43 (02) :352-357
[2]  
BEEVERS DG, 1976, Q J MED, V45, P401
[3]   ROLE OF ALDOSTERONE IN CONTROL OF SODIUM EXCRETION IN PATIENTS WITH ADVANCED CHRONIC RENAL-FAILURE [J].
BERL, T ;
KATZ, FH ;
HENRICH, WL ;
DETORRENTE, A ;
SCHRIER, RW .
KIDNEY INTERNATIONAL, 1978, 14 (03) :228-235
[4]   Antagonists of aldosterone and proteinuria in patients with CKD: An uncontrolled pilot study [J].
Bianchi, S ;
Bigazzi, R ;
Campese, VM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) :45-51
[5]   Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].
Chaturvedi, N .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379
[6]   CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES [J].
CONN, JW ;
KNOPF, RF ;
NESBIT, RM .
AMERICAN JOURNAL OF SURGERY, 1964, 107 (01) :159-172
[7]   Aldosterone receptor blockade and the role of eplerenone: evolving perspectives [J].
Epstein, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) :1984-1992
[8]   Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on renal function [J].
Epstein, M ;
Campese, VM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :2-14
[9]   Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications [J].
Epstein, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :677-688
[10]   Eplerenone reduces proteinuria in type II diabetes mellitus: Implications for aldosterone involvement in the pathogenesis of renal dysfunction [J].
Epstein, M ;
Buckalew, V ;
Altamirano, J ;
Roniker, B ;
Krause, S ;
Kleiman, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) :249A-249A